Abstract
Current practice and outcome for patients with lung cancer were determined by retrospective case note review of a random sample of all lung cancer cases registered for a calendar year and augmented by review of all surgical and radical radiotherapy cases. A total of 262 patients - 231 patients less than 75 years of age and 31 patients more than 75 years of age - represented 83% of the random sample. Eighty-three per cent of patients were seen within 2 weeks of referral. One-third reported symptoms occurring for less than 1 month and one-third had experienced symptoms for more than 3 months. The median time interval from first hospital contact until the making of a management decision was 18 days. The median interval from first contact to surgery was 63 days, and to starting radical radiotherapy 70 days. Histological confirmation was obtained in 69% of patients. Ten per cent of all lung cancer patients were calculated to have received chemotherapy. Five per cent of the whole cohort had definitive surgery and 64% of these were judged to be free of the disease at 3 years. Overall survival was 9% at 3 years, with no differences relating to cell type or area of residence. Many areas of good practice have been identified, but the lack of tumour staging or performance status data, the low proportion receiving chemotherapy or definitive surgery and the poor outcome after radical radiotherapy indicate the need for prospective audit and feedback of results. The long time interval from management decision to surgery and radiotherapy suggests organizational issues which need attention.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kesson, E., Bucknall, C., McAlpine, L. et al. Lung cancer -- management and outcome in Glasgow, 1991--92. Br J Cancer 78, 1391–1395 (1998). https://doi.org/10.1038/bjc.1998.690
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.690
This article is cited by
-
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group
Medical Oncology (2012)
-
A population-based study of gefitinib in patients with non-small cell lung cancer
Medical Oncology (2009)
-
Survival from lung cancer in England and Wales up to 2001
British Journal of Cancer (2008)
-
Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?
British Journal of Cancer (2003)
-
Lung cancer referral patterns in the former Yorkshire region of the UK
British Journal of Cancer (2002)